2025 年的期刊文章 · 第 9 页

共 1491 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2025-09-15 到 2025-08-29。

按期刊、按主题看 →

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 页

SMMR Bayesian Methods Latent Variables & Mixtures · 发表于 2025-09-15

Bayesian clustering prior with overlapping indices for effective use of multisource external data

Xuetao Lu, J Jack Lee

摘要

The use of external data in clinical trials offers numerous advantages, such as reducing enrollment, increasing study power, and shortening trial duration. In Bayesian inference, information in external data can be transferred into an informative prior for future borrowing (i.e. prior synthesis). However, multisource external data often exhibits heterogeneity, which can cause information distortion during the prior synthesizing. Clustering helps identifying the heterogeneity, enhancing the congruence between synthesized prior and external data. Obtaining optimal clustering is challenging due to the trade-off between congruence with external data and robustness to future data. We introduce two overlapping indices: the overlapping clustering index and the overlapping evidence index . Using these indices alongside a K-means algorithm, the optimal clustering result can be identified by balancing this trade-off and applied to construct a prior synthesis framework to effectively borrow information from multisource external data. By incorporating the (robust) meta-analytic predictive (MAP) prior within this framework, we develop (robust) Bayesian clustering MAP priors. Simulation studies and real-data analysis demonstrate their advantages over commonly used priors in the presence of heterogeneity. Since the Bayesian clustering priors are constructed without needing the data from prospective study, they can be applied to both study design and data analysis in clinical trials.

SiM Functional Data Bayesian Methods · 发表于 2025-09-14

Tutorial on Bayesian Functional Regression Using Stan

Ziren Jiang, Ciprian Crainiceanu, Erjia Cui

SiM Longitudinal Data Clinical Trials Nonparametric & Semiparametric · 发表于 2025-09-14

Power and Sample Size Calculation for Multivariate Longitudinal Trials Using the Longitudinal Rank Sum Test

Dhrubajyoti Ghosh, Xiaoming Xu, Sheng Luo, for the CPP Integrated Parkinson's Database

摘要

Neurodegenerative diseases such as Alzheimer's and Parkinson's often exhibit complex, multivariate longitudinal outcomes that require advanced statistical methods to comprehensively evaluate treatment efficacy. The Longitudinal Rank Sum Test (LRST) offers a nonparametric framework to assess global treatment effects across multiple longitudinal endpoints without requiring multiplicity corrections. This study develops a robust methodology for power and sample size estimation specific to the LRST, integrating theoretical derivations, asymptotic properties, and practical estimation techniques under large sample conditions. Validation through numerical simulations demonstrates the accuracy of the proposed methods, while real‐world applications to clinical trials in Alzheimer's disease (AD) and Parkinson's disease (PD) highlight their practical significance. This framework facilitates the design of efficient, well‐powered trials, advancing the evaluation of treatments for complex diseases with multivariate longitudinal outcomes.

SiM Diagnostics & Prediction Clinical Trials Bayesian Methods · 发表于 2025-09-14

Bayesian Adaptive Enrichment Design for Continuous Biomarkers

Yue Tu, Yusha Liu, Wendy J. Mack, Lindsay A. Renfro

摘要

With the advent of precision medicine and targeted therapies in cancer, new challenges in the statistical design of clinical trials have naturally emerged. Most randomized clinical trial designs incorporating predictive biomarkers (those associated with treatment efficacy) assume biomarkers are dichotomous, or dichotomize naturally continuous biomarkers upfront, or find cut points mid‐way through the trial to classify patients as biomarker‐positive or biomarker‐negative. However, these practices ignore or discard information about continuous and possible nonlinear or non‐monotone prognostic or predictive effects. In this article, we propose a novel adaptive enrichment trial design to handle continuous biomarkers with any effect shape, including Bayesian marker‐adaptive randomization. We demonstrate that this design can correctly make marker‐specific trial decisions with high efficiency, resulting in improved performance and patient‐centered decisions compared to adaptive cut‐point selection approaches without adaptive randomization that further ignore or oversimplify true underlying marker relationships.

Biometrics Networks & Graphs · 发表于 2025-09-13

A group distributional ICA method for decomposing multi-subject diffusion tensor imaging

Guangming Yang, Ben Wu, Jian Kang, Ying Guo

摘要

Diffusion tensor imaging (DTI) is a frequently used imaging modality to investigate white matter fiber connections of human brain. DTI provides an important tool for characterizing human brain structural organization. Common goals in DTI analysis include dimension reduction, denoising, and extraction of underlying structure networks. Blind source separation methods are often used to achieve these goals for other imaging modalities. However, there has been very limited work for multi-subject DTI data. Due to the special characteristics of the 3D diffusion tensor measured in DTI, existing methods such as standard independent component analysis (ICA) cannot be directly applied. We propose a Group Distributional ICA (G-DICA) method to fill this gap. G-DICA represents a fundamentally new blind source separation method that separates the parameters in the distribution function of the observed imaging data as a mixture of independent source signals. Decomposing multi-subject DTI using G-DICA uncovers structural networks corresponding to several major white matter fiber bundles in the brain. Through simulation studies and real data applications, the proposed G-DICA method demonstrates superior performance and improved reproducibility compared to the existing method.

JASA High-Dimensional Latent Variables & Mixtures · 发表于 2025-09-12

SOFARI: High-Dimensional Manifold-Based Inference

Zemin Zheng, Xin Zhou, Yingying Fan, Jinchi Lv

摘要

Multi-task learning is a widely used technique for harnessing information from various tasks. Recently, the sparse orthogonal factor regression (SOFAR) framework, based on the sparse singular value decomposition (SVD) within the coefficient matrix, was introduced for interpretable multi-task learning, enabling the discovery of meaningful latent feature-response association networks across different layers. However, conducting precise inference on the latent factor matrices has remained challenging due to the orthogonality constraints inherited from the sparse SVD constraints. In this article, we suggest a novel approach called the high-dimensional manifold-based SOFAR inference (SOFARI), drawing on the Neyman near-orthogonality inference while incorporating the Stiefel manifold structure imposed by the SVD constraints. By leveraging the underlying Stiefel manifold structure that is crucial to enabling inference, SOFARI provides easy-to-use bias-corrected estimators for both latent left factor vectors and singular values, for which we show to enjoy the asymptotic mean-zero normal distributions with estimable variances. We introduce two SOFARI variants to handle strongly and weakly orthogonal latent factors, where the latter covers a broader range of applications. We illustrate the effectiveness of SOFARI and justify our theoretical results through simulation examples and a real data application in economic forecasting. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*

JRSSB Nonparametric & Semiparametric Bayesian Methods · 发表于 2025-09-11

Scalable Bayesian inference for heat kernel Gaussian processes on manifolds

Junhui He, Guoxuan Ma, Jian Kang, Ying Yang

摘要

We establish a scalable manifold learning method and theory, motivated by the problem of estimating functional magnetic resonance imaging activation manifolds in the Human Connectome Project. Our primary contribution is the development of an efficient estimation technique for heat kernel Gaussian processes in the exponential family model. This approach handles large sample sizes n, preserves the intrinsic geometry of data, and significantly reduces computational complexity from O(n3) to O(n) via a novel reduced-rank approximation of the graph Laplacian’s transition matrix and a truncated singular value decomposition for the eigenpair computation. The numerical experiments demonstrate the scalability and improved accuracy of our method for manifold learning tasks involving complex large-scale data.

SiM Bayesian Methods · 发表于 2025-09-11

Hierarchical Grouped Horseshoe Priors for Subgroup Identification and Estimation

Ethan M. Alt, Anil Anderson, Qing Li, Jia Hua, Amarjot Kaur, Joseph G. Ibrahim

摘要

A common issue in randomized clinical trials (RCTs) is the identification of subgroups and the estimation of their effects. Typically, RCTs are not powered to estimate the effects of subgroups. However, in some circumstances, treatment may work for some groups and not others, and it is of interest to identify these subgroups and estimate their treatment effects. In this paper, we introduce a novel hierarchical grouped horseshoe prior (HGHP) for subgroup identification and estimation. We show via simulation that our proposed approach yields superior positive predictive value and narrower credible intervals compared to other shrinkage priors. We apply our method to a real clinical trial for COVID‐19.

JRSSB Nonparametric & Semiparametric · 发表于 2025-09-10

Simplifying debiased inference via automatic differentiation and probabilistic programming

Alex Luedtke

摘要

We introduce an algorithm that simplifies the construction of efficient estimators, making them accessible to a broader audience. ‘Dimple’ takes as input computer code representing a parameter of interest and outputs an efficient estimator. Unlike standard approaches, it does not require users to derive a functional derivative known as the efficient influence function. Dimple avoids this task by applying automatic differentiation to the statistical functional of interest. Doing so requires expressing this functional as a composition of primitives satisfying a novel differentiability condition. Dimple also uses this composition to determine the nuisances it must estimate. In software, primitives can be implemented independently of one another and reused across different estimation problems. We provide a proof-of-concept Python implementation and showcase through examples how it allows users to go from parameter specification to efficient estimation with just a few lines of code.

Biometrika Testing & Uncertainty · 发表于 2025-09-10

Model-free selective inference under covariate shift via weighted conformal p -values

Ying Jin, Emmanuel J Candès

摘要

Summary: This paper introduces novel weighted conformal $ p $-values and methods for model-free selective inference. The problem is as follows: given test units with covariates $ X $ and missing responses $ Y $, how do we select units for which the responses $ Y $ are larger than user-specified values while controlling the proportion of false positives? Can we achieve this without modelling assumptions on the data and without restriction on the model for predicting the responses? Finally, methods should be applicable when there is a covariate shift between training and test data, which commonly occurs in practice. We answer these questions by first leveraging any prediction model to produce a class of well-calibrated weighted conformal $ p $-values, which control the Type-I error in detecting a large response. These $ p $-values cannot be passed onto classical multiple testing procedures since they may not obey a well-known positive dependence property. Hence, we introduce weighted conformal selection, a new procedure that controls the false discovery rate in finite samples. Besides prediction-assisted candidate selection, weighted conformal selection (i) allows us to infer multiple individual treatment effects, and (ii) extends to outlier detection with inlier distribution shifts. We demonstrate performance via simulations and applications to causal inference, drug discovery and outlier detection datasets.

SiM Missing Data & Measurement Error · 发表于 2025-09-10

Accounting for Misclassification of Binary Outcomes in External Control Arm Studies for Unanchored Indirect Comparisons: Simulations and Applied Example

Mikail Nourredine, Antoine Gavoille, Côme Lepage, Behrouz Kassai‐Koupai, Michel Cucherat, Fabien Subtil

摘要

Single‐arm control trials are increasingly proposed as a potential approach for treatment evaluation. However, the limitations of this design restrict its methodological acceptability. Regulatory agencies have raised concerns about this approach, although it is sometimes required in applications based solely on such studies. Consequently, the need for accurate indirect treatment comparisons has become critical, especially when constructing external control arms using routinely collected data as outcome measurements may differ from those recorded in the single‐arm trial leading to potential misclassification of outcomes. This study aimed to quantify the bias from ignoring misclassification of a binary outcome within unanchored indirect comparisons, through simulations, and to propose a likelihood‐based method to correct this bias (i.e., the outcome‐corrected model). Simulations demonstrated that ignoring misclassification results in significant bias and poor coverage probabilities. In contrast, the outcome‐corrected model reduced bias, improved 95% confidence interval coverage probability and root mean square error in various scenarios. The methodology was applied to two hepatocellular carcinoma trials illustrating a practical application. The findings underscore the importance of addressing outcome misclassification in indirect comparisons. The proposed correction method may improve reliability in unanchored indirect treatment comparisons.

JRSSB Other · 发表于 2025-09-10

A stratified L 2-discrepancy with application to space-filling designs

Ye Tian, Hongquan Xu

摘要

Space-filling designs are widely used in computer experiments. We propose a stratified L2-discrepancy to evaluate the uniformity of a design when the design domain is stratified into various subregions. Weights are used to adjust preferences for the uniformity over subregions in each stratification. The stratified L2-discrepancy is easy to compute, satisfies a Koksma–Hlawka type inequality, and overcomes the curse of dimensionality that exists for other discrepancies. It is applicable to a broad class of designs, and covers several minimum aberration-type criteria as special cases. Strong orthogonal arrays of maximum strength are shown to have low stratified L2-discrepancies, and thus are suitable for computer experiments. In addition, we develop a lower bound for the stratified L2-discrepancy and provide a construction method for designs that achieve the lower bound. We further introduce a general version of the stratified L2-discrepancy for evaluating designs with flexible stratification properties.

SiM Clinical Trials Bayesian Methods · 发表于 2025-09-09

Using Confidence Distributions in Final and Interim Analyses for Single‐Arm Studies or Platform Trials Consisting of Single‐Arm Studies

Günter Heimann, Peter Jacko, Tom Parke

摘要

Confidence distributions are a frequentist alternative to the Bayesian posterior distribution. These confidence distributions have received more attention in the recent past because of their simplicity. In rare diseases, oncology, or in pediatric drug development, single‐arm trials, or platform trials consisting of a series of single‐arm trials are increasingly being used, both to establish proof‐of‐concept and to provide pivotal evidence for a marketing application. Often, these single‐arm trials are designed as two‐stage designs, or they include sequential or continuous monitoring approaches. They are analyzed using standard frequentist, Bayesian, or other methods. In this paper, we describe how to define analysis strategies based on confidence distributions for such single‐arm trials or for platform trials that consist of a series of single arm trials. We focus on binary endpoints and show how to define the corresponding decision rules for final and interim analyses and how to derive their operating characteristics exactly, for example, without simulation. Our approach uses predictive probabilities rather than conditional probabilities (as with stochastic curtailment) to define the interim decision rules. It can be applied to platform, basket, and umbrella trials that consist of a series of single‐arm trials but also to stand‐alone single arm trials.

SiM Testing & Uncertainty · 发表于 2025-09-09

Minimum Area Confidence Set Optimality for Simultaneous Confidence Bands for Percentiles With Applications to Drug Shelf‐Life Estimation

Lingjiao Wang, Yang Han, Wei Liu, Frank Bretz

摘要

One important property of any drug product is its stability over time. A key objective in drug stability studies is to estimate the shelf‐life of a drug, involving a suitable definition of the true shelf‐life and the construction of an appropriate estimate of the true shelf‐life. Simultaneous confidence bands (SCBs) for percentiles in linear regression are valuable tools for determining the shelf‐life in drug stability studies. In this paper, we propose a novel criterion, the Minimum Area Confidence Set (MACS) criterion, for finding the optimal SCB for percentile regression lines. This criterion focuses on the area of the constrained regions for the newly proposed pivotal quantities, which are generated from the confidence set for the unknown parameters of an SCB. We employ the new pivotal quantities to construct exact SCBs over any finite covariate intervals and use the MACS criterion to compare several SCBs of different forms. The optimal SCB under the MACS criterion can be used to construct the interval estimate of the true shelf‐life. Furthermore, a new computationally efficient method is proposed for calculating the critical constants of exact SCBs for percentile regression lines. A real data example on drug stability is provided for illustration.

JASA Other · 发表于 2025-09-09

Estimating Racial Disparities When Race is Not Observed

Cory McCartan, Robin Fisher, Jacob Goldin, Daniel E. Ho, Kosuke Imai

摘要

Estimating racial disparities without access to individual-level racial information is a common challenge in economic and policy settings. We develop a statistical method that relaxes the strong independence assumption of common race imputation approaches like Bayesian-Improved Surname Geocoding (BISG). Our identification assumption is that surname is conditionally independent of the outcome given (unobserved) race, residence location, and other observed characteristics. The proposed approach reduces error by up to 84% relative to BISG when estimating racial differences in political party registration. In our application, we estimate racial differences in who benefits from the home mortgage interest deduction using individual-level tax data from the U.S. Internal Revenue Service. Our analysis reveals that many fewer Black and Hispanic filers claim the HMID than White and Asian filers. We also find that the racial gaps in homeownership rates alone cannot explain this disparity. *(abstract via OpenAlex)*

SiM Clinical Trials Testing & Uncertainty · 发表于 2025-09-08

Testing for Similarity of Dose Response in Multiregional Clinical Trials

Holger Dette, Lukas Koletzko, Frank Bretz

摘要

This article addresses the problem of determining whether the dose response relationships between subgroups and the full population in a multiregional trial are similar. Similarity is assessed in terms of the maximal deviation between the dose response curves. We consider a parametric framework and develop two powerful bootstrap tests: one for assessing the similarity between the dose response curves of a single subgroup and that of the full population, and another for comparing the dose response curves of multiple subgroups with that of the full population. We prove the validity of these tests, investigate their finite sample properties through a simulation study and illustrate the methodology with a case study.

SiM Diagnostics & Prediction Longitudinal Data Bayesian Methods · 发表于 2025-09-08

A New Algorithm for Sampling Parameters in a Structured Correlation Matrix With Application to Estimating Optimal Combinations of Muscles to Quantify Progression in Duchenne Muscular Dystrophy

Michael K. Kim, Michael J. Daniels, William D. Rooney, Rebecca J. Willcocks, Glenn A. Walter, Krista H. Vandenborne

摘要

The goal of this paper is to estimate an optimal combination of biomarkers for individuals with Duchenne muscular dystrophy (DMD), which provides the most sensitive combinations of biomarkers to assess disease progression (in this case, optimal with respect to standardized response mean (SRM) for 4 muscle biomarkers). The biomarker data is incomplete (missing and irregular) multivariate longitudinal data. We propose a normal model with structured covariance designed for our setting. To sample from the posterior distribution of parameters, we develop a Markov Chain Monte Carlo (MCMC) algorithm to address the positive definiteness constraint on the structured correlation matrix. In particular, we propose a novel approach to compute the support of the parameters in the structured correlation matrix; we modify the approach from [1] on the set of the largest possible submatrices of the correlation matrix, where the correlation parameter is a unique element. For each posterior sample, we compute the optimal weights of our construct. We conduct data analysis and simulation studies to evaluate the algorithm and the frequentist properties of the posteriors of correlations and weights. We found that the lower extremities are the most responsive muscles at the early and late ambulatory disease stages, and the biceps brachii is the most responsive at the nonambulatory disease stage.

SiM Longitudinal Data · 发表于 2025-09-07

Equivalency Between the Generalized Bivariate Bernoulli Model Dependency Test and a Logistic Regression Model With Interaction Effects

Kazi Md Farhad Mahmud, Yanming Li, Devin C. Koestler

摘要

Background: Binary endpoints measured at two timepoints—such as pre‐ and post‐treatment—are common in biomedical and healthcare research. The Generalized Bivariate Bernoulli Model (GBBM) provides a specialized framework for analyzing such bivariate binary data, allowing for formal tests of covariate‐dependent associations conditional on baseline outcomes. Despite its potential utility, the GBBM remains underutilized due to the lack of direct implementation in standard statistical software. Moreover, we contend that the comparison made in the original publication between the GBBM dependency test and the regressive logistic regression model has shortcomings and does not provide an ideal basis for evaluating the model's performance. Methods: In this paper, we propose a standard logistic regression model with an interaction term and demonstrate that it yields an equivalent dependency test to the GBBM approach. This equivalence is established conceptually, theoretically, and empirically. Extensive simulations compared the power of the GBBM dependency test with: (a) dependency test from the regressive logistic model; (b) test derived from the logistic regression model with interaction; and (c) the Pearson Chi‐square test. We also applied these methods to infant mortality data from the Bangladesh Demographic and Health Survey (BDHS). Results: The power of the GBBM dependency test differs from the regressive logistic regression model used as a benchmark in the original paper that introduced the GBBM methodology. In contrast, the power and type 1‐error rate of the GBBM dependency test and the logistic regression model with interaction described herein are equivalent across varying effect sizes and sample sizes. Conclusion: Our work reveals that a widely available and flexible logistic regression model can serve as a practical alternative to the GBBM dependency test, enhancing accessibility for researchers. Moreover, this approach provides a foundation for extending dependency analyses to more complex longitudinal binary data structures, broadening its applicability in biomedical research.

SiM Bayesian Methods Clinical Trials · 发表于 2025-09-07

A Bayesian Multi‐Factorial Design and Analysis for Estimating Combined Effects of Multiple Interventions in a Pragmatic Clinical Trial to Improve Dementia Care

Keith S. Goldfeld, Corita R. Grudzen, Manish N. Shah, Abraham A. Brody, Joshua Chodosh, Rebecca Anthopolos

摘要

Factorial study designs can be important for understanding the effectiveness of interventions when multiple interventions are under investigation. In this design setting, a unit of randomization can be assigned to any combination of interventions. The rationale for taking this kind of approach can vary depending on the specific questions targeted by the research. These questions, in turn, have implications for the way in which the analyses will be conducted. The goal in this paper is to describe how we developed a factorial design along with a Bayesian analytic plan for a large cluster‐randomized trial—the Emergency Departments LEading the transformation of Alzheimer's and Dementia care (ED‐LEAD) study—focused on improving care for persons living with dementia.

SiM Genetics & Omics Nonparametric & Semiparametric · 发表于 2025-09-05

RISE: Two‐Stage Rank‐Based Identification of High‐Dimensional Surrogate Markers Applied to Vaccinology

Arthur Hughes, Layla Parast, Rodolphe Thiébaut, Boris P. Hejblum

摘要

In vaccine trials with long‐term participant follow‐up, it is of great importance to identify surrogate markers that accurately infer long‐term immune responses. These markers offer practical advantages such as providing early, indirect evidence of vaccine efficacy, and can accelerate vaccine development while identifying potential biomarkers. High‐throughput technologies such as RNA‐sequencing have emerged as promising tools for understanding complex biological systems and informing new treatment strategies. However, these data are high‐dimensional, presenting unique statistical challenges for existing surrogate marker identification methods. We introduce Rank‐based Identification of high‐dimensional SurrogatE Markers (RISE), a novel approach designed for small sample, high‐dimensional settings typical in modern vaccine experiments. RISE uses a nonparametric univariate test to screen variables for promising candidates, followed by surrogate evaluation on independent data. Our simulation studies demonstrate RISE's desirable properties, including type one error rate control and empirical power under various conditions. Applying RISE to a clinical trial for inactivated influenza vaccination, we sought to identify genes whose expression could serve as a surrogate for the induced immune response. This analysis revealed a signature of genes appearing to function as a reasonable surrogate for the neutralizing antibody response. Pathways related to innate antiviral signaling and interferon stimulation were strongly represented in this derived surrogate, providing a clear immunological interpretation.

SiM Clinical Trials · 发表于 2025-09-05

Multiplicity Control in Oncology Clinical Trials With a Binary Surrogate Endpoint‐Based Drop‐The‐Losers Design

Weibin Zhong, Jing‐ou Liu, Chenguang Wang

摘要

Typical phase 1 oncology studies identify the maximum tolerated dose as the “optimal” dose for subsequent phases. With the advancement of molecular targeted agents and immunotherapies, however, evaluating two or more doses has become increasingly critical for dose selection. Such evaluation is often done in phase 2 studies in a randomized manner. In this article, we evaluate the strategy of applying an adaptive phase 2/3 seamless design for dose selection in oncology studies. Specifically, we consider the “drop‐the‐losers” design, where multiple treatment arms and a control arm are administered during the initial stage, and a more effective arm is identified for later stages by a binary surrogate endpoint such as overall response. We derive the theoretical type I error inflation scale and conduct simulation studies to illustrate the impact of various factors on the type I error inflation in such designs. Furthermore, we demonstrate the findings through the design of a lung cancer trial and introduce a software that implements the proposed design.

SiM Bayesian Methods · 发表于 2025-09-05

Modeling Joint Health Effects of Environmental Exposure Mixtures With Bayesian Additive Regression Trees

Jacob R. Englert, Stefanie T. Ebelt, Howard H. Chang

摘要

Studying the association between mixtures of environmental exposures and health outcomes can be challenging due to issues such as correlation among the exposures and non‐linearities or interactions in the exposure‐response function. For this reason, one common strategy is to fit flexible nonparametric models to capture the true exposure‐response surface. However, once such a model is fit, further decisions are required when it comes to summarizing the marginal and joint effects of the mixture on the outcome. In this work, we describe the use of soft Bayesian additive regression trees (BART) to estimate the exposure‐risk surface describing the effect of mixtures of chemical air pollutants and temperature on asthma‐related emergency department (ED) visits during the warm season in Atlanta, Georgia, from 2011 to 2018. BART is chosen for its ability to handle large datasets and for its flexibility to be incorporated as a single component of a larger model. We then summarize the results using a strategy known as accumulated local effects to extract meaningful insights into the mixture effects on asthma‐related morbidity. Notably, we observe negative associations between and asthma ED visits and harmful associations between ozone and asthma ED visits, both of which are particularly strong on lower temperature days.

JASA Nonparametric & Semiparametric · 发表于 2025-09-05

Kernel Density Estimation with Polyspherical Data and its Applications

Eduardo García-Portugués, Andrea Meilán-Vila

摘要

A kernel density estimator for data on the polysphere Sd1×⋯×Sdr, with r,d1,…,dr≥1, is presented in this paper. We derive the main asymptotic properties of the estimator, including mean square error, normality, and optimal bandwidths. We address the kernel theory of the estimator beyond the von Mises–Fisher kernel, introducing new kernels that are more efficient and investigating normalizing constants, moments, and sampling methods thereof. Plug-in and cross-validated bandwidth selectors are also obtained. As a spin-off of the kernel density estimator, we propose a nonparametric k-sample test based on the Jensen–Shannon divergence that is consistent against alternatives with non-homogeneous densities. Numerical experiments illuminate the asymptotic theory of the kernel density estimator and demonstrate the superior performance of the k-sample test with respect to parametric alternatives in certain scenarios. Our smoothing methodology is applied to the analysis of the morphology of a sample of hippocampi of infants embedded on the high-dimensional polysphere (S2)168 through skeletal representations (s-reps). *(abstract via OpenAlex)*

JASA High-Dimensional · 发表于 2025-09-05

Integrated Path Stability Selection

Omar Melikechi, Jeffrey W. Miller

摘要

Stability selection is a popular method for improving feature selection algorithms. One of its key attributes is that it provides theoretical upper bounds on the expected number of false positives, E(FP), enabling false positive control in practice. However, stability selection often selects few features because existing bounds on E(FP) are relatively loose. In this paper, we introduce a novel approach to stability selection based on integrating stability paths rather than maximizing over them. This yields upper bounds on E(FP) that are much stronger than previous bounds, leading to significantly more true positives in practice for the same target E(FP). Furthermore, our method requires no more computation than the original stability selection algorithm. We demonstrate the method on simulations and real data from two cancer studies. *(abstract via PubMed)*

SiM Latent Variables & Mixtures · 发表于 2025-09-05

Incorporating Heterogeneity in Mixed Hidden Markov Models With an Application to the Sleep‐Wake Cycle

Jordan Aron, Paul S. Albert, Mark B. Fiecas

摘要

The sleep–wake cycle plays an important and far‐reaching role in health. By utilizing personal physical activity monitors (PAMs), inferences about the sleep–wake cycle can be made. Hidden Markov models (HMMs) have been applied in this area as an accurate unsupervised approach. To account for heterogeneity in activity levels, we developed a mixed HMM that allows for individual differences. Through extensive simulations, we quantified the added gains relative to a standard HMM from using a mixed HMM to account for heterogeneity across several realistic scenarios. We found that mixed HMMs are often more accurate than standard HMMs when follow‐up times are shorter. In situations with many repeated measurements per individual, a standard and mixed HMM have similar levels of accuracy, although a standard HMM is faster and easier to implement. Afterward, we applied our HMMs to actigraphy data from the National Health and Nutrition Examination Survey. We present results on sleep summary statistics by age and BMI. Summary statistics about the sleep–wake cycle extracted by the standard and mixed HMM were qualitatively similar. Differences in results, however, were likely driven by the heterogeneity in physical activity due to BMI and age, which we identified using a post hoc investigation of the data‐driven clusters produced by the mixed HMM.

JASA Causal Inference Spatial & Time Series · 发表于 2025-09-05

Design and Analysis of Randomized Trials to Estimate Spatio-Temporally Heterogeneous Treatment Effects

Samuel I. Watson, Thomas A. Smith

摘要

In this article, we consider randomized trial design to evaluate interventions with spatially or spatio-temporally heterogeneous effects. A common approach in this setting is the cluster randomized trial. In many cases, clusters are constituted as discrete subdivisions of a contiguous area of interest. However, cluster trials designed in this way may suffer from issues of spillover and may fail to capture the relevant spatial and temporal effects. We define possible randomization schemes and consider the identifiability of the causal effects of the intervention and the required trial design assumptions. We develop mixed model and dose response function specifications that satisfy the required assumptions. We show that the dose response functions are identifiable under certain randomization schemes and compare the performance of estimators in a simulation-based study. We demonstrate that obtaining valid inference may be difficult in these settings but that design-based estimators of confidence intervals and p-values generally perform well. Finally, we present design examples, including a re-analysis of data from a trial of an interventions to reduce the risk of malaria. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*

JASA Bayesian Methods · 发表于 2025-09-05

Additive Multi-Index Gaussian Process Modeling, with Application to Multi-Physics Surrogate Modeling of the Quark-Gluon Plasma

Kevin Li, Simon Mak, J.-F. Paquet, Steffen A. Bass

摘要

The Quark-Gluon Plasma (QGP) is a unique phase of nuclear matter, theorized to have filled the Universe shortly after the Big Bang. A critical challenge in studying the QGP is that, to reconcile experimental observables with theoretical parameters, one requires many simulation runs of a complex physics model over a high-dimensional parameter space. Each run is computationally expensive, requiring thousands of CPU hours, thus limiting physicists to only several hundred runs. Given limited training data for high-dimensional prediction, existing surrogate models often yield poor predictions with high predictive uncertainties, leading to imprecise scientific findings. To address this, we propose a new Additive Multi-Index Gaussian process (AdMIn-GP) model, which leverages a flexible additive structure on low-dimensional embeddings of the parameter space. This is guided by prior scientific knowledge that the QGP is dominated by multiple distinct physical phenomena (i.e., multi-physics), each involving a small number of latent parameters. The AdMIn-GP models for such embedded structure within a flexible Bayesian nonparametric framework, which facilitates efficient model fitting via a carefully constructed variational inference approach with inducing points. We show the effectiveness of the AdMIn-GP via a suite of numerical experiments and our QGP application, where we demonstrate considerably improved surrogate modeling performance over existing models. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*

SMMR Clinical Trials Optimization & Learning Theory Bayesian Methods · 发表于 2025-09-05

A robust Bayesian dose optimization design with backfill and randomization for phase I/II clinical trials

Yingjie Qiu, Mingyue Li

摘要

The integration of backfill cohorts into Phase I clinical trials has garnered increasing interest within the clinical community, particularly following the “Project Optimus” initiative by the U.S. Food and Drug Administration, as detailed in their final guidance of August 2024. This approach allows for the collection of additional clinical data to assess safety and activity before initiating trials that compare multiple dosages. For novel cancer treatments such as targeted therapies, immunotherapies, antibody-drug conjugates, and chimeric antigen receptor T-cell therapies, the efficacy of a drug may not necessarily increase with dose levels. Backfill strategies are especially beneficial as they enable the continuation of patient enrollment at lower doses while higher doses are being explored. We propose a robust Bayesian design framework that borrows information across dose levels without imposing stringent parametric assumptions on dose–response curves. This framework minimizes the risk of administering subtherapeutic doses by jointly evaluating toxicity and efficacy, and by effectively addressing the challenge of delayed outcomes. Simulation studies demonstrate that our design not only generates additional data for late stage studies but also enhances the accuracy of optimal dose selection, improves patient safety, reduces the number of patients receiving subtherapeutic doses, and shortens trial duration across various realistic trial settings.

SiM Genetics & Omics · 发表于 2025-09-05

A Multi‐Phenotype Approach to Joint Testing of Main Genetic and Gene‐Environment Interaction Effects

Saurabh Mishra, Arunabha Majumdar

摘要

Gene‐environment (GxE) interactions crucially contribute to complex phenotypes. The statistical power of a GxE interaction study is limited mainly due to weak GxE interaction effect sizes. Joint tests of the main genetic and GxE effects for a univariate phenotype were proposed to utilize the individually weak GxE effects to improve the discovery of associated genetic loci. We develop a testing procedure to evaluate combined genetic and GxE effects on multiple related phenotypes to enhance the power by merging pleiotropy in the main genetic and GxE effects. We base the approach on a general linear hypothesis testing framework for multivariate regression of continuous phenotypes. We implement the generalized estimating equations (GEE) technique under the seemingly unrelated regressions (SUR) setup for binary or mixed phenotypes. We use extensive simulations to show that the test for joint multi‐phenotype genetic and GxE effects outperforms the univariate joint test of genetic and GxE effects and the test for multi‐phenotype GxE effect concerning power when there is pleiotropy. The test produces a higher power than the test for the multi‐phenotype marginal genetic effect for a weak genetic and substantial GxE effect. For more prominent genetic effects, the latter performs better with a limited increase in power. Overall, the multi‐phenotype joint approach offers robust, high power across diverse simulation scenarios. We apply the methods to lipid phenotypes with sleep duration as an environmental factor in the UK Biobank. The proposed approach identified ten independent associated genetic loci missed by other competing methods. In a multi‐phenotype analysis of apolipoproteins, ApoA1, and ApoB, our approach discovered two distinct loci considering sleep duration as the environmental factor.

SiM Longitudinal Data · 发表于 2025-09-05

A Location‐Scale Joint Model for Studying the Link Between the Time‐Dependent Subject‐Specific Variability of Blood Pressure and Competing Events

Léonie Courcoul, Christophe Tzourio, Mark Woodward, Antoine Barbieri, Hélène Jacqmin‐Gadda

摘要

Given the high incidence of cardio and cerebrovascular diseases (CVD), and their association with morbidity and mortality, their prevention is a major public health issue. A high level of blood pressure is a well‐known risk factor for these events, and an increasing number of studies suggest that blood pressure variability may also be an independent risk factor. However, these studies suffer from significant methodological weaknesses. In this work, we propose a new location‐scale joint model for the repeated measures of a marker and competing events. This joint model combines a mixed model including a subject‐specific and time‐dependent residual variance modeled through random effects, and cause‐specific proportional intensity models for the competing events. The risk of events may depend simultaneously on the current value of the variance, as well as, the current value and the current slope of the marker trajectory. The model is estimated by maximizing the likelihood function using the Marquardt–Levenberg algorithm. The estimation procedure is implemented in an R‐package and is validated through a simulation study. This model is applied to study the association between blood pressure variability and the risk of CVD and death from other causes. Using data from a large clinical trial on the secondary prevention of stroke, we find that the current individual variability of blood pressure is associated with the risk of CVD and death. Moreover, the comparison with a model without heterogeneous variance shows the importance of taking into account this variability in the goodness‐of‐fit and for dynamic predictions.

SMMR High-Dimensional Functional Data Longitudinal Data · 发表于 2025-09-04

A comparison of semi-parametric statistical modeling approaches to dynamic classification of irregularly and sparsely sampled curves

Ruben Deneer, Zhuozhao Zhan, Edwin Van den Heuvel, Astrid GM van Boxtel, Arjen-Kars Boer, Natal AW van Riel, Volkher Scharnhorst

摘要

This study describes and compares the performance of several semi-parametric statistical modeling approaches to dynamically classify subjects into two groups, based on an irregularly and sparsely sampled curve. The motivating example of this study is the diagnosis of a complication following cardiac surgery, based on repeated measures of a single cardiac biomarker where early detection enables prompt intervention by clinicians. We first simulate data to compare the dynamic predictive performance over time for growth charts, conditional growth charts, a varying-coefficient model, a generalized functional linear model and longitudinal discriminant analysis. Our results demonstrate that functional regression approaches that implicitly incorporate historic information through random effects, provide superior discriminative ability compared to approaches that do not take historic information into account or explicitly model historic information through autoregressive terms. Semi-parametric modeling approaches show a benefit in terms of dynamic discriminative ability compared to the clinical practice of using a fixed threshold on the raw measured value. Under high degrees of sparsity the functional regression approaches are less advantageous compared to varying-coefficient models or quantile regression. The class imbalance of the outcome affects the historic and non-historic approaches in equal measure, with lower event rates reducing performance. Finally, the functional regression and varying-coefficient model were applied to a real-world clinical dataset to demonstrate their performance and application.

Biometrics Bayesian Methods Nonparametric & Semiparametric · 发表于 2025-09-02

Nonparametric Bayesian approach for dynamic borrowing of historical control data

Tomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, Masahiko Gosho

摘要

When incorporating historical control data into the analysis of current randomized controlled trial data, it is critical to account for differences between the datasets. When the cause of difference is an unmeasured factor and adjustment for only observed covariates is insufficient, it is desirable to use a dynamic borrowing method that reduces the impact of heterogeneous historical controls. We propose a nonparametric Bayesian approach that addresses between-trial heterogeneity and allows borrowing historical controls homogeneous with the current control. Additionally, to emphasize conflict resolution between historical controls and the current control, we introduce a method based on the dependent Dirichlet process (DP) mixture. The proposed methods can be implemented using the same procedure, regardless of whether the outcome data comprise aggregated study-level data or individual participant data. We also develop a novel index of similarity between the historical and current control data, based on the posterior distribution of the parameter of interest. We conduct a simulation study and analyze clinical trial examples to evaluate the performance of the proposed methods compared to existing methods. The proposed method, based on the dependent DP mixture, can accurately borrow from homogeneous historical controls while reducing the impact of heterogeneous historical controls compared to the typical DP mixture. The proposed methods outperform existing methods in scenarios with heterogeneous historical controls, in which the meta-analytic approach is ineffective.

Biometrics Spatial & Time Series Bayesian Methods Latent Variables & Mixtures · 发表于 2025-09-01

Joint disease mapping for bivariate count data with residual correlation due to unknown number of common cases

Edouard Chatignoux, Zoé Uhry, Laurent Remontet, Isabelle Albert

摘要

The joint spatial distribution of two count outcomes (eg, counts of two diseases) is usually studied using a Poisson shared component model (P-SCM), which uses geographically structured latent variables to model spatial variations that are specific and shared by both outcomes. In this model, the correlation between the outcomes is assumed to be fully accounted for by the latent variables. However, in this article, we show that when the outcomes have an unknown number of cases in common, the bivariate counts exhibit a positive “residual” correlation, which the P-SCM wrongly attributes to the covariance of the latent variables, leading to biased inference and degraded predictive performance. Accordingly, we propose a new SCM based on the Bivariate-Poisson distribution (BP-SCM hereafter) to study such correlated bivariate data. The BP-SCM decomposes each count into counts of common and distinct cases, and then models each of these three counts (two distinct and one common) using Gaussian Markov Random Fields. The model is formulated in a Bayesian framework using Hamiltonian Monte Carlo inference. Simulations and a real-world application showed the good inferential and predictive performances of the BP-SCM and confirm the bias in P-SCM. BP-SCM provides rich epidemiological information, such as the mean levels of the unknown counts of common and distinct cases, and their shared and specific spatial variations.

Biometrics Bayesian Methods Genetics & Omics Latent Variables & Mixtures · 发表于 2025-09-01

Bayesian inference for copy number intra-tumoral heterogeneity from single-cell RNA-sequencing data

PuXue Qiao, Chun Fung Kwok, Guoqi Qian, Davis J McCarthy

摘要

Copy number alterations (CNA) are important drivers and markers of clonal structures within tumors. Understanding these structures at single-cell resolution is crucial to advancing cancer treatments. The objective is to cluster single cells into clones and identify CNA events in each clone. Early attempts often sacrifice the intrinsic link between cell clustering and clonal CNA detection for simplicity and rely heavily on human input for critical parameters such as the number of clones. Here, we develop a Bayesian model to utilize single-cell RNA sequencing (scRNA-seq) data for automatic analysis of intra-tumoral clonal structure concerning CNAs, without reliance on prior knowledge. The model clusters cells into sub-tumoral clones, identifies the number of clones, and simultaneously infers the clonal CNA profiles. It synergistically incorporates input from gene expression and germline single-nucleotide polymorphisms. A Gibbs sampling algorithm has been implemented and is available as an R package Chloris. We demonstrate that our new method compares strongly against existing software tools in terms of both cell clustering and CNA profile identification accuracy. Application to human metastatic melanoma and anaplastic thyroid tumor data demonstrates accurate clustering of tumor and non-tumor cells and reveals clonal CNA profiles that highlight functional gene expression differences between clones from the same tumor.

Biometrics Other · 发表于 2025-08-29

Revisiting optimal allocations for binary responses: insights from considering type-I error rate control

Lukas Pin, Sofía S Villar, William F Rosenberger

摘要

This work revisits optimal response-adaptive designs from a type-I error rate perspective, highlighting when and how much these allocations exacerbate type-I error rate inflation—an issue previously undocumented. We explore a range of approaches from the literature that can be applied to reduce type-I error rate inflation. However, we found that all of these approaches fail to give a robust solution to the problem. To address this, we derive 2 optimal allocation proportions, incorporating the more robust score test (instead of the Wald test) with finite sample estimators (instead of the unknown true values) in the formulation of the optimization problem. One proportion optimizes statistical power, and the other minimizes the total number of failures in a trial while maintaining a fixed variance level. Through simulations based on an early phase and a confirmatory trial, we provide crucial practical insight into how these new optimal proportion designs can offer substantial patient outcomes advantages while controlling type-I error rate. While we focused on binary outcomes, the framework offers valuable insights that naturally extend to other outcome types, multi-armed trials, and alternative measures of interest.

SMMR Missing Data & Measurement Error Clinical Trials · 发表于 2025-08-29

Implementing response-adaptive designs when responses are missing: Impute or ignore?

Mia S Tackney, Sofía S Villar

摘要

Missing data is a widespread issue in clinical trials, but is particularly problematic for digital health interventions where disengagement is common and outcomes are likely to be missing not at random (MNAR). Trials that use response-adaptive designs need to handle missingness online and not simply at the end of the trial. We propose a novel online imputation strategy which allows previous imputations to be re-imputed given updated estimates of success probabilities. We additionally consider: (i) truncation of deterministic algorithms to prevent extreme realised treatment imbalance and (ii) changing the random component of semi-randomised algorithms. Through a simulation study based on a trial for a digital smoking cessation intervention, we illustrate how the strategy for handling missing responses can affect the exploration-exploitation tradeoff and the bias of the estimated success probabilities at the end of the trial. In the settings explored, we found that the exploration-exploitation tradeoff is affected particularly when arms have very different rates of missingness and we identified combinations of response-adaptive designs and missingness strategies that are particularly problematic. Further, we show that estimated success probabilities at the end of the trial can be biased not only due to optimistic sampling, but potentially also due to an MNAR missingness mechanism.

SMMR Clinical Trials · 发表于 2025-08-29

Exact power and sample size in clinical trials with two co-primary binary endpoints

Gosuke Homma, Takuma Yoshida

摘要

Binary endpoints are used widely to evaluate treatment effects during clinical trials. Although clinical trials in many therapeutic areas evaluate a single binary endpoint as the primary endpoint, clinical trials in certain therapeutic areas require two co-primary binary endpoints to evaluate treatment benefit multi-dimensionally. We consider the situation in which evidence of effects on both co-primary endpoints is necessary to conclude that the intervention is effective, which differs from approaches by which significance on at least one endpoint is sufficient for trial success. When designing clinical trials with two co-primary binary endpoints, consideration of correlation between the endpoints can increase trial power and consequently reduce the required sample size, leading to improved efficiency. For clinical trials with two co-primary binary endpoints, methods for calculating power and sample size have been proposed, but they are based on approximations or require Monte Carlo integration. Alternatively, we propose methods for calculating the exact power and sample size in clinical trials with two co-primary binary endpoints. The proposed methods are useful for any statistical test for binary endpoints. Numerical investigation under various scenarios demonstrated that our proposed methods can incorporate consideration of the correlation between two co-primary binary endpoints in sample size calculation, thereby allowing the required sample size to be reduced. We demonstrate that the exact power for the required sample size calculated using our proposed method is approximately equal to target power. Finally, we present application of our proposed methods to a clinical trial of relapsing or refractory eosinophilic granulomatosis with polyangiitis.

JASA Missing Data & Measurement Error Causal Inference Testing & Uncertainty · 发表于 2025-08-29

Design-Based Causal Inference with Missing Outcomes: Missingness Mechanisms, Imputation-Assisted Randomization Tests, and Covariate Adjustment

Siyu Heng, Jiawei Zhang, Yang Feng

摘要

Design-based causal inference, also known as randomization-based or finite-population causal inference, is one of the most widely used causal inference frameworks, largely due to the merit that its validity can be guaranteed by study design (e.g., randomized experiments) and does not require assuming specific outcome-generating distributions or super-population models. Despite its advantages, design-based causal inference can still suffer from other issues, among which outcome missingness is a prevalent and significant challenge. This work systematically studies the outcome missingness problem in design-based causal inference. First, we propose a general and flexible outcome missingness mechanism that can facilitate finite-population-exact randomization tests of no treatment effect. Second, under this general missingness mechanism, we propose a general framework called "imputation and re-imputation" for conducting randomization tests in design-based causal inference with missing outcomes. We prove that our framework can still ensure finite-population-exact type-I error rate control even when the imputation model was misspecified or when unobserved covariates or interference exist in the missingness mechanism. Third, we extend our framework to conduct covariate adjustment in randomization tests and construct finite-population-valid confidence regions with missing outcomes. Our framework is evaluated via extensive simulation studies and applied to a large-scale randomized experiment. *(abstract via PubMed)*

Biometrics Bayesian Methods · 发表于 2025-08-29

Bayesian inference: theory, methods, computations by Silvelyn Zwanzig and Rauf Ahmad, Chapman & Hall/CRC, 2024, ISBN: 9781003221623, https://www.routledge.com/Bayesian-Inference-Theory-Methods-Computations/Zwanzig-Ahmad/p/book/9781032118093

Kenneth Rice

摘要

Zwanzig and Ahmad’s Bayesian Inference: Theory, Methods, Computation is a textbook at around the level of upper undergraduate, MS, or early PhD students, providing a mathematical and theoretical-statistics view of its material. With around 300 pages, its main chapters introduce Bayesian inference and modeling, discuss prior choice, and describe Bayesian linear models, before somewhat more general coverage of estimation, testing, and some computational techniques. Although these topics are obviously not those of a research monograph, several chapters do give brief treatments of recently developed ideas, for example, approximate Bayesian computation and variational Bayes. There are also non-essential chapters on decision theory and asymptotics, to which interested readers might return after a first reading. Each chapter comes with a selection of exercises, for which solutions are helpfully provided. The book has a formal mathematical style: theorems and proofs are given throughout, and while the presentation deliberately stays away from the full rigor of measure theory, it seems clear that the authors would prefer to present the material that way. The text also seems strongly focused on getting to the end of each proof; there is, for example, no post-proof discussion of how estimates from Normal-Normal setups can be viewed as weighted averages of prior and likelihood contributions. Similarly, all the algebra for the Jeffreys-Lindley paradox is presented, but without then explaining why the result is such a bombshell. The mathematical style also extends to the examples, which are presented with minimal applied context and even less applied interpretation of what the analysis has revealed—or discussion of the analyses’ limitations. So, the meaning of “inference” in the title is strictly technical. *(abstract via OpenAlex)*

SMMR Bayesian Methods Latent Variables & Mixtures Survival Analysis · 发表于 2025-08-29

A Bayesian approach towards the identification of latent subgroups

Ethan M Alt, Peter Yi Guan, Larry Leon, Amarjot Kaur, Yue Shentu, Guoqing Diao, Xianming Tan, Joseph G Ibrahim

摘要

In clinical trials, it is often of interest to know whether treatment works differently for some groups than others, known as heterogeneity of treatment effect. Such subgroup analysis is complicated to conduct because trials are typically not powered to find subgroups. Furthermore, it is difficult to identify characteristics of patients pertaining to such subgroups. In this article, we propose a semiparametric mixture model to identify subgroups with time-to-event outcomes. Specifically, we assume a proportional hazards model with subgroup-specific piecewise constant baseline hazards, where the subgroup-specific treatment effect is assumed to be the same within each subgroup. The probability of belonging to a certain subgroup is a function of patient prognostic factors. Adopting a Bayesian approach, classification uncertainty is taken into account. We demonstrate the utility of our approach via simulation and an application to data from a real clinical trial in HIV research.

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 页